US11807629B2: selinexor cross-references 90 other patent(s) via PubChem structural search (6 likely-same-scaffold hit(s))

Real cross-patent screening for US11807629B2 (Karyopharm Therapeutics Inc., 'Crystalline forms of Selinexor'). Target compound selinexor resolved to canonical SMILES and screened against PubChem's patent-compound index. Result: 90 unique other patents reference structurally near-identical (6 hits) or related-scaffold (6 hits) compounds. Search completed in 26.3s. Structural overlap only; no infringement conclusion stated.